There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tandem Diabetes Care (TNDM – Research Report), Apyx Medical (APYX – Research Report) and Leap Therapeutics (LPTX – Research Report) with bullish sentiments.
Tandem Diabetes Care (TNDM)
In a report released today, Alexander Nowak from Craig-Hallum assigned a Buy rating to Tandem Diabetes Care. The company’s shares closed last Wednesday at $28.53, close to its 52-week low of $23.60.
According to TipRanks.com, Nowak is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tandem Diabetes Care with a $45.29 average price target, a 66.8% upside from current levels. In a report released yesterday, Barclays also reiterated a Buy rating on the stock with a $71.00 price target.
See the top stocks recommended by analysts >>
Apyx Medical (APYX)
In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to Apyx Medical. The company’s shares closed last Tuesday at $5.35.
According to TipRanks.com, Hewitt is a 4-star analyst with an average return of
Apyx Medical has an analyst consensus of Strong Buy, with a price target consensus of $6.50, implying a 24.5% upside from current levels. In a report issued on July 5, Lake Street also maintained a Buy rating on the stock with a $9.00 price target.
Leap Therapeutics (LPTX)
In a report released today, Mara Goldstein from Mizuho Securities maintained a Buy rating on Leap Therapeutics, with a price target of $20.00. The company’s shares closed last Tuesday at $3.07, close to its 52-week low of $2.70.
According to TipRanks.com, Goldstein is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Leap Therapeutics with a $10.63 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TNDM:
